Two medical researchers, Alan Mutch and Gerry Lefevre, both of the department of anesthesia, have made discoveries that could lead to two new products to assist in the management of patients undergoing cardiac surgery or surgery following severe lung injury.

The biotechnology products will be commercialized and marketed by a new company, BioVar Life Support Inc., owned jointly by the two researchers, the University of Manitoba, and the Crocus Investment Fund, which invested $500,000. The Crocus Fund provides capital to Manitoba-owned businesses, and has targeted biotechnology as a growth industry in the province.

This is the first time the U of M has held equity in a company created as a direct result of research conducted at the university. The university can expect substantial economic benefits as the BioVar products are further developed and marketed.

More highlights of the research achievements of our faculty and students.

• New Project to Evaluate Drug Therapy
• Flood of the Century Brings Out Best from U of M
• Medical Research Council Recognizes Outstanding
• Manitobans Named to All Three Major Research Councils
• Notable Research Funding
• Strategic Grants
• Geographer Studies Northern Sea Ice Effect on Climate

• SMART Park to Encourage University-Industry Interaction
• World's "Smartest" Bridge Opens in Headingley
• Technology Transfer

• Rockefeller Foundation Funds AIDS Project
• TRLabs Renews Partnership Agreement
• University Partners with Team Cormorant